Clorox Co: Form 10-K for the period ended Jun 30, 2023
Filed with the SEC on Aug 10, 2023 and accepted by EDGAR at Aug 10, 2023, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-07-01 to 2023-06-30 | $7.39bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2022-07-01 to 2023-06-30 | $4.48bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2022-07-01 to 2023-06-30 | $2.91bn | us-gaap:GrossProfit |
| Research and development | 12 months2022-07-01 to 2023-06-30 | $138.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-07-01 to 2023-06-30 | $1.18bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 12 months2022-07-01 to 2023-06-30 | $90.0m | us-gaap:InterestExpense |
| Income tax | 12 months2022-07-01 to 2023-06-30 | $77.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-07-01 to 2023-06-30 | $149.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-07-01 to 2023-06-30 | $1.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-07-01 to 2023-06-30 | $1.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-07-01 to 2023-06-30 | 124,181,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-07-01 to 2023-06-30 | $1.16bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-07-01 to 2023-06-30 | $228.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-07-01 to 2023-06-30 | $583.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-07-01 to 2023-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-06-30 | $367.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $1.83bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $5.95bn | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $1.92bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-06-30 | $5.56bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-06-30 | $2.48bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-06-30 | $0 | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-06-30 | $50.0m | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-06-30 | $220.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000021076-23-000037. Last ingested by Listed: Oct 29, 2026, 07:11 ET. Listed shows no prices and gives no investment advice.